Published in Women's Health Weekly, December 14th, 1998
The technique, dubbed the Campaign Test, is designed to be used with the standard Pap smear but will pick out and mark abnormal cells that can be easily missed in laboratory analysis.
Preliminary tests have shown the method is extremely accurate. If large-scale trials, due to begin in 18 months, are successful, then the test could be available worldwide within three years. This is good news for British health authorities in light to a series of problems in Britain's cervical screening...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.